These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Activation of Hageman factor (factor XII) by bismuth subgallate, a hemostatic agent. Thorisdottir H; Ratnoff OD; Maniglia AJ J Lab Clin Med; 1988 Oct; 112(4):481-6. PubMed ID: 3171356 [TBL] [Abstract][Full Text] [Related]
4. Effect of bismuth subgallate (local hemostatic agent) on wound healing in rats. Histological and histometric findings. Tramontina VA; Machado MA; Nogueira Filho Gda R; Kim SH; Vizzioli MR; Toledo Sd Braz Dent J; 2002; 13(1):11-6. PubMed ID: 11870955 [TBL] [Abstract][Full Text] [Related]
5. [Topic usage of bismuth subgallate as a hemostatic in tonsillectomy]. García de Hombre MA; Pérez Peñate A An Otorrinolaringol Ibero Am; 2006; 33(3):301-5. PubMed ID: 16881556 [TBL] [Abstract][Full Text] [Related]
6. Bismuth subgallate-epinephrine paste in adenotonsillectomies. Hatton RC Ann Pharmacother; 2000 Apr; 34(4):522-5. PubMed ID: 10772440 [TBL] [Abstract][Full Text] [Related]
7. Effect of bismuth subgallate on nitric oxide and prostaglandin E2 production by macrophages. Lin CY; Shen YH; Wu SH; Lin CH; Hwang SM; Tsai YC Biochem Biophys Res Commun; 2004 Mar; 315(4):830-5. PubMed ID: 14985087 [TBL] [Abstract][Full Text] [Related]
8. Effect of bismuth subgallate (a hemostatic agent) on bone repair; a histologic, radiographic and histomorphometric study in rats. Puia SA; Renou SJ; Rey EA; Guglielmotti MB; Bozzini CE Int J Oral Maxillofac Surg; 2009 Jul; 38(7):785-9. PubMed ID: 19375279 [TBL] [Abstract][Full Text] [Related]
10. [Myoclonic encephalopathy caused by bismuth salts. Efficacy of treatment with dimercaprol]. Molina JA; Calandre L; Bermejo F; Posadas F; Fernández-Ortega JD Med Clin (Barc); 1989 Jun; 93(1):20-2. PubMed ID: 2770373 [TBL] [Abstract][Full Text] [Related]
11. Bismuth subgallate as a topical haemostatic agent at the palatal wounds: a histologic study in dogs. Kim SH; Tramontina VA; Papalexiou V; Luczsyzyn SM; De Lima AA; do Prado AM Int J Oral Maxillofac Surg; 2012 Feb; 41(2):239-43. PubMed ID: 22209184 [TBL] [Abstract][Full Text] [Related]
12. Bismuth subgallate: a safe means to a faster adenotonsillectomy. Wormald PJ; Sellars SL J Laryngol Otol; 1994 Sep; 108(9):761-2. PubMed ID: 7964138 [TBL] [Abstract][Full Text] [Related]
13. Bismuth Subgallate Toxicity in the Age of Online Supplement Use. Sampognaro P; Vo KT; Richie M; Blanc PD; Keenan K Neurologist; 2017 Nov; 22(6):237-240. PubMed ID: 29095326 [TBL] [Abstract][Full Text] [Related]
14. The influence of bismuth subgallate and adrenaline paste upon operating time and operative blood loss in tonsillectomy. Callanan V; Curran AJ; Smyth DA; Gormley PK J Laryngol Otol; 1995 Mar; 109(3):206-8. PubMed ID: 7745335 [TBL] [Abstract][Full Text] [Related]
15. Does bismuth subgallate have haemostatic effects in tonsillectomy? Sørensen WT; Henrichsen J; Bonding P Clin Otolaryngol Allied Sci; 1999 Feb; 24(1):72-4. PubMed ID: 10196655 [TBL] [Abstract][Full Text] [Related]
16. Bismuth subgallate as a topical hemostatic agent at palatal donor sites. Kim SH; Tramontina VA; Papalexiou V; Luczyszyn SM Quintessence Int; 2010 Sep; 41(8):645-649. PubMed ID: 20657853 [TBL] [Abstract][Full Text] [Related]
17. Letter: Mental illness or metal illness? Bismuth subgallate. Coffey GL; Graham JW Med J Aust; 1974 Dec; 2(24):885. PubMed ID: 4453262 [No Abstract] [Full Text] [Related]
20. Experimental study on the effects of bismuth subgallate on the inflammatory process and angiogenesis of the oral mucosa. Couto EV; Ballin CR; Sampaio CP; Maeda CA; Ballin CH; Dassi CS; Miura LY Braz J Otorhinolaryngol; 2016; 82(1):17-25. PubMed ID: 26614041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]